Rohto Pharmaceutical Co.,Ltd. (4527-T) Stock Split, History Data
Working capital analysis
In terms of working capital, Rohto Pharmaceutical Co.,Ltd. maintains a healthy position.
The total current assets of the company are valued at $190246000000.
This represents a growth rate of 15.788% compared to the previous year.
Breaking down the current assets, the cash and investments are worth $79951000000, exhibiting a growth rate of 9.836% year-on-year.
The receivables, another significant portion of the current assets, are valued at $60656000000.
The year-on-year growth rate for receivables is 17.364%.
The inventory, which forms a critical part of the assets, is valued at $41062000000.
This represents a healthy year-on-year growth of 22.474%
On the liabilities side, the company's current liabilities total $80162000000.
This reflects a growth rate of 12.134% over the previous year, indicating the company's financial obligations are well under control.
2023
2022
2021
2020
2019
2018
Cash and investments
79951.00
72791.00
52964.00
45307.00
37856.00
30532.00
Receavebles
60656.00
51682.00
47865.00
50416.00
44364.00
41420.00
Inventory
41062.00
33527.00
27925.00
30625.00
30260.00
26228.00
Other
29547.00
24678.00
20975.00
21276.00
16069.00
16248.00
Total Current Assets
190246.00
164306.00
133071.00
130108.00
116402.00
114428.00
Acc Payable
16025.00
13660.00
9603.00
11324.00
11005.00
12098.00
Short Term Debt
4177.00
8033.00
2312.00
2105.00
3745.00
4151.00
Other Current Liab
29368.00
27256.00
10008.00
11913.00
10391.00
40758.00
Current Liabilities
80162.00
71488.00
56471.00
62117.00
60760.00
61464.00
Capital Structure
When examining the capital structure of Rohto Pharmaceutical Co.,Ltd., it is clear that the company manages a robust portfolio.
These earnings represent the profits that Rohto Pharmaceutical Co.,Ltd. has chosen to reinvest in the business rather than distribute as dividends.
